• Publications
  • Influence
Cutaneous side-effects of kinase inhibitors and blocking antibodies.
Although kinase inhibitors raise hope for people with cancer, patients and their clinicians are commonly confronted with the cutaneous side-effects that are associated with the use of these drugs.Expand
  • 497
  • 29
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3
BACKGROUND Olaparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, has previously shown efficacy in a phase 2 study when given in capsule formulation to all-comer patients with platinum-sensitive,Expand
  • 613
  • 25
  • PDF
Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma.
OBJECTIVES The objectives of this study were to evaluate the interest and the potential therapeutic value of systematic pelvic and paraaortic lymphadenectomy in patients with stage Ib and II cervicalExpand
  • 139
  • 11
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Centre Leon Bérard, University Claude Bernard Lyon & GINECO group, Lyon; Gustave Roussy & GINECO group, Villejuif, France; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Hospital deExpand
  • 65
  • 11
  • PDF
Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of
PURPOSE The aim of this prospective study conducted in three French comprehensive cancer centers was to evaluate the therapeutic impact on survival of laparoscopic para-aortic (PA) staging surgery inExpand
  • 128
  • 10
Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay.
Granulosa cell tumors (GCT) are ovarian neoplasms that tend to recur and spread in the pelvis and the abdomen several years after the initial treatment. Anti-Mülerian hormone (AMH) is a reliableExpand
  • 153
  • 8
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
BACKGROUND The purpose was to determine the factors influencing nodal involvement and topography of pelvic and paraaortic node involvement in ovarian carcinoma. STUDY DESIGN Between 1985 and 2001,Expand
  • 208
  • 7
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.
PURPOSE The aim of this study was to evaluate the prognostic factors and morbidities of patients undergoing completion surgery for locally advanced-stage cervical cancer after initial chemoradiationExpand
  • 76
  • 7
Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues.
Since the last two decades, the feasibility of fertility-sparing surgery (FSS) in early-stage epithelial ovarian cancer (EOC) has been explored by several teams and is reconsidered in this systematicExpand
  • 48
  • 7
Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors.
OBJECTIVE To assess clinical outcome and fertility in patients treated conservatively for a low malignant potential (LMP) ovarian tumor. DESIGN Retrospective study. SETTING Gynecologic oncologyExpand
  • 201
  • 6
...
1
2
3
4
5
...